mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.099 |
0.06 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.06 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.076 |
0.07 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.07 |